Recent findings have illuminated a compelling link between gut imbalance, known as intestinal dysbiosis, and neurological manifestations in LC cases. The data is quite remarkable. 🦠🧠

For some time, observers have noted that certain patients with Long COVID experience significant recovery leaps when using therapies focused on the microbiome. This latest research offers a plausible scientific rationale for those observations.

A team of Canadian researchers has established that this condition is linked to a distinct microbiome pattern that encourages neuroinflammation. To reach this conclusion, the investigators first mapped the gut characteristics of patients suffering from neurological issues. Subsequently, they obtained stool samples from these individuals and introduced them into mice that were bred to be germ-free.

Following this transplantation, the animals began to suffer from compromised intestinal barriers and displayed symptoms of neuroinflammation.

To determine the cause, the scientists investigated the specific function of gut bacterial extracellular vesicles, known as GBEV. These elements serve as signaling molecules that bacteria in the digestive tract release to interact with peers and modulate their host environment.

Upon analyzing the blood of the mice after the transplant, the team discovered that these circulating GBEVs were the primary agents driving the observed biological alterations.

1/